NANOCOR THERAPEUTICS, INC.

Basic Information

870 MARTIN LUTHER KING JR BLVD
CHAPEL HILL, NC, 27514-2600

Company Profile

n/a

Additional Details

Field Value
DUNS: 6064300
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Gene Based Therapy for Congestive Heart Failure P2 SBIR

    Amount: $2,623,563.00

    DESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and increment ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Gene Based Therapy for Congestive Heart Failure

    Amount: $640,383.00

    DESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and increment ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government